Sign in

CIK 0001840233 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Xilio Therapeutics, Inc.

Sign in to watch
Ticker
XLO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
851623397
Phone
617-833-1027
Business address
828 WINTER STREET, WALTHAM, MA, 02451
  1. 10-K Report Annual Report
  2. 8-K Event Results of operations
  3. SCHEDULE 13G Stake Statement of Beneficial Ownership
  4. 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure · Other events
  5. 8-K Event Regulation FD disclosure · Other events
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. 8-K Event Unregistered share sale · Regulation FD disclosure · Other events
  13. SC 13G/A Stake Amended Statement of Ownership
  14. SC 13G/A Stake Amended Statement of Ownership
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations · Regulation FD disclosure · Other events
  19. 4 Insider Changes in Ownership
  20. SC 13G Stake Amended Statement of Ownership

Page 7 of 19 · 361 filings